Clinical Trials Browser

Phase 2 × Practice Guidelines as Topic × Head & Neck × Clear all

Maxillary Sinus Neoplasms, Mouth Neoplasms, Parotid Neoplasms, Tongue Neoplasms, Tonsillar Neoplasms

NCT06532279 2026-04-03

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT06995508 2026-02-17

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Phase 2 Recruiting

66 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05077072 2025-10-20

Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients

Phase 2 Active not recruiting

28 enrolled

Head & Neck

Head and Neck Carcinoma

Clinical Trials

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients